Infectious Disease Attending and Director of HIV Prevention Research
Beth Israel Deaconess Medical Center
Professor of Medicine
Harvard Medical School
Medical Research Director
The Fenway Institute
- Biology of HIV prevention
- HIV and STDs
- Anti-HIV vaccines
- Post-exposure prophylaxis
- Antiretroviral therapy
- HIV epidemiology
- HIV in MSM, in women, and in Asia
Dr Mayer is a Professor of Medicine at Harvard Medical School and Medical Research Director of Fenway Community Health Center in Boston, Massachusetts. He is an Attending Physician in Infectious Diseases and Director of HIV Prevention Research at Beth Israel Deaconess Medical Center.
- National Board, American Foundation for AIDS Research
- National Board, HIV Medicine Association, Infectious Diseases Society of America
- Board of Directors, International Center for Equal Health Care Access (ICEHA)
- Special Topics Editor, HIV/AIDS – Clinical Infectious Diseases
- Massachusetts Governor's Recognition Award for AIDS Research (1986)
- Visiting Professor, University of Queensland, Brisbane, Australia (1989)
- Guest Key Note Speaker, Annual Meeting, Philippine College of Physicians, Manila (1988)
- Peter Medoff Award, Search for a Cure, Boston, MA (1998)
- Massachusetts Community Recognition Award, AIDS Action Committee, Boston (1990)
- Award of Courage, Honoring with Pride, American Foundation for AIDS Research, New York, NY (2003)
- University of Pennsylvania, BA Psychology (1972)
- Northwestern University, MD (1977)
- Boston Beth Israel/Harvard, Residency in Internal Medicine (1977–1980)
- Harvard/Brigham & Women's Hospital, Infectious Disease Fellowship (1980–1983)
- New England Epidemiology Institute, Summer Course
- Wang WK, Mayer KH, Essex M, Lee TH. Sequential change of cysteine residues in hypervariable region 1 of glycoprotein 120 in primary HIV type 1 isolates of subtype B. AIDS Res Hum Retroviruses.1996;12:1195-1197.
- Wank WK, Essex M, McLane MF, Mayer KH, et al. Pattern of gp 120 sequence divergence linked to a lack of clinical progression in human immunodeficiency virus type 1 infection. Proc Natl Acad Sci USA. 1996;93:6693-6697.
- Zierler S, Witbeck B, Mayer KH. Sexual violence against women living with or at risk for HIV infection. Am J Prevent Med.1996;12:304-310.
- Seage GR, Mayer KH, Lenderking WR, Wold C, Gross M, Goldstein R, Cai B, Heeren T, Hingson R, Holmberg S. HIV and hepatitis B infection and risk behavior in young gay and bisexual men. Public Health Rep.1997;112:158-167.
- Xu C, Politch JA, Tucker L, Mayer KH, Seage GR, Anderson DA. Factors associated with increased levels of HIV type 1 DNA in semen. J Infect Dis. 1997;176:941-947.
- Quayle AJ, Xu C, Mayer KH, Anderson DA. T lymphocytes and macrophages, but not motile spermatozoa, are a significant source of HIV in semen. J Infect Dis.1997;176:960-968.
- Haimovici F, Mayer KH, Anderson DJ. Quantitation of HIV-1 specific IgG, IgA, and IgM antibodies in human genital tract secretions. JAIDS.1997;15:185-191.
- Anderson DJ, Politch JA, Tucker LD, Fichorova R, Haimovici F, Tuomala RE, Mayer KH. Quantitation of mediators of inflammation and immunity in genital tract secretions and their relevance to HIV type 1 transmission. AIDS Res Hum Retroviruses. 1998;14:S43-S49.
- Quale AJ, Coston WMP, Trocha A, Kalams S, Mayer KH, Anderson DJ. Detection of HIV-1 specific cytotoxic T lymphocytes in the semen of HIV-infected individuals. J Immunol.1998;161:4406-4410.
- Mayer KH, Boswell S, Goldstein R, Lo W, Xu C, Tucker L. Persistence of human immunodeficiency virus in semen after adding indinavir to combination antiretroviral therapy. Clin Infect Dis. 1999;28:1252-1259.
Marrazzo JM, del Rio C, Holtgrave DR, Cohen MS, Kalichman SC, Mayer KH, Montaner JSG, Wheeler DP, Grant RM, Grinsztejn B, Kumarasamy N, Shoptaw S, Walensky RP, Dabis F, Sugarman J, Benson CA. HIV Prevention in Clinical Care Settings: 2014 Recommendations of the International Antiviral Society–USA Panel. JAMA. 2014.